Literature DB >> 12559634

TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes.

Masataka Nishimura1, Hiroshi Obayashi, Ikuko Mizuta, Hirokazu Hara, Tetsuo Adachi, Mitsuhiro Ohta, Hisataka Tegoshi, Michiaki Fukui, Goji Hasegawa, Hirofumi Shigeta, Yoshihiro Kitagawa, Koji Nakano, Ryuji Kaji, Naoto Nakamura.   

Abstract

The human leukocyte antigen (HLA) class III region, located on chromosome 6p21, has been regarded as one of the susceptible loci for type 1 diabetes. Because it contains many genes related to inflammatory and immune responses, including tumor necrosis factor (TNF), lymphotoxin-alpha (LT-alpha), and allograft inflammatory factor 1 (AIF-1) genes, it is unclear which gene within the class III region is responsible for the susceptibility to the disease. We sequenced the AIF-1 gene region and detected three novel polymorphisms, all of which were diallelic and localized at introns. Then, we investigated AIF-1, TNF, and LT-alpha gene polymorphisms in 165 patients with type 1 diabetes, consisting of 90 patients with young-onset type 1 diabetes, 75 patients with adult-onset type 1 diabetes, and 200 control patients. We also analyzed TNF receptors type 1 (TNFR1) and type 2 (TNFR2) gene polymorphisms, located on chromosome 12p13 and 1p36, respectively. Although there were significant differences between type 1 diabetes patients and controls in the distributions of TNF promoter polymorphisms at position -1031 and -857, and LT-alpha gene NcoI polymorphism, none of them was independently associated with the disease after two-locus analysis with HLA class II alleles. We detected the significantly increased frequency of the -383C allele, located in the TNFR-1 promoter region, in both young-onset and adult-onset diabetes patients compared with controls. In addition, the -383C allele was found to be associated with higher expression of the TNFR1 gene than that of -383A allele in in vitro expression. These results suggest that the TNFR1 gene region might be a susceptible locus to type 1 diabetes in Japanese.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559634     DOI: 10.1016/s0198-8859(02)00799-1

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  17 in total

1.  Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse.

Authors:  Tao Xie; Lee Rowen; Begoña Aguado; Mary Ellen Ahearn; Anup Madan; Shizhen Qin; R Duncan Campbell; Leroy Hood
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

Review 2.  Genetics of type 1 diabetes.

Authors:  Janelle A Noble; Henry A Erlich
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

3.  Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility.

Authors:  Janelle A Noble; Ana M Valdes; Julie A Lane; Amy E Green; Henry A Erlich
Journal:  Hum Immunol       Date:  2006-10-30       Impact factor: 2.850

4.  The lung endothelin system: a potent therapeutic target with bosentan for the amelioration of lung alterations in a rat model of diabetes mellitus.

Authors:  A Cayir; R A Ugan; A Albayrak; D Kose; E Akpinar; Y Cayir; H T Atmaca; Z Bayraktutan; M Kara
Journal:  J Endocrinol Invest       Date:  2015-04-07       Impact factor: 4.256

5.  CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura.

Authors:  Francesca Rossi; Silvia Mancusi; Giulia Bellini; Domenico Roberti; Francesca Punzo; Simona Vetrella; Sofia Maria Rosaria Matarese; Bruno Nobili; Sabatino Maione; Silverio Perrotta
Journal:  Haematologica       Date:  2011-08-09       Impact factor: 9.941

6.  Allograft inflammatory factor-1 in myeloid cells drives autoimmunity in type 1 diabetes.

Authors:  Diana M Elizondo; Nailah Zd Brandy; Ricardo L da Silva; Tatiana R de Moura; Michael W Lipscomb
Journal:  JCI Insight       Date:  2020-05-21

7.  Modulation of type 1 diabetes susceptibility by tumor necrosis factor alpha -308 G/A and lymphotoxin alpha +249 A/G haplotypes and lack of linkage disequilibrium with predisposing DQB1-DRB1 haplotypes in Bahraini patients.

Authors:  Mouna Stayoussef; Fayza A Al-Jenaidi; Abduljabbar Al-Abbasi; Khadija Al-Ola; Haya Khayyat; Touhami Mahjoub; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

8.  Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data.

Authors:  C Brorsson; N T Hansen; K Lage; R Bergholdt; S Brunak; F Pociot
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

9.  Associations between TNF gene polymorphisms (-308 A/G, -238 A/G, -1031 C/T and -857 T/C) and genetic susceptibility to T1D: a meta-analysis.

Authors:  Peng-Fei Wen; Xiao-Song Wang; Min Zhang; Han Cen; Hai-Feng Pan; Qian-Ling Ye; Chen Mao; Dong-Qing Ye
Journal:  Endocrine       Date:  2014-02-11       Impact factor: 3.633

10.  The -383A>C TNFRI polymorphism is associated with soluble levels and clinical activity in rheumatoid arthritis.

Authors:  Y Valle; J R Padilla-Gutiérrez; N M Torres-Carrillo; I Y Ledezma-Lozano; E G Corona-Sánchez; M Vázquez-Del Mercado; H Rangel-Villalobos; J I Gámez-Nava; L González-López; José Francisco Muñoz-Valle
Journal:  Rheumatol Int       Date:  2009-07-07       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.